Jacobian
PrivateLast Round
Series C
Apr 22, 2024
Total Funding Raised
$59.4M
Company Overview
Jacobian is a healthcare technology company that provides an AI-powered, structured medical reporting platform for radiology and pathology to streamline diagnostic workflows and enhance clinical decision-making.
Sector
Healthcare & Life Sciences
Verticals
Medical Imaging, Medical AI, Document Management, Vertical SaaS
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Jacobian Comparables
Compare Jacobian with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rad AI | 81% | |
| Neo Q Quality in Imaging GmbH | 79% | |
| Sirona Medical | 79% |
Jacobian Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 22, 2024 | ||||
| Debt | Apr 17, 2023 | ||||
| Series B | Apr 20, 2020 | ||||
| VC Round | Oct 4, 2018 | ||||
| Grant | Nov 24, 2017 | ||||
Series A | Apr 12, 2017 |
Key People
Founding team and executive leadership
Jacobian Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Investitions- und Strukturbank Rheinland-Pfalz | Series C, Series A |
| European Commission | Grant |
| TVM Capital | Series C |
| Cascara Ventures | Series C, Series A |
| European Investment Bank Group | Debt |
| Wessel Management | Series B, Series C, VC Round |
| Bayern Kapital | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 16, 2025
Announced Jacobian(TM) to accelerate AI-powered reporting.
- Oct 16, 2025
Plan to acquire Fluency for Imaging announced.
Jacobian Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Jacobian's valuation, stock price, and market status.
Is Jacobian a public or private company?
Jacobian is a private company.
What is the current stock price of Jacobian?
Jacobian is a private company, so its shares have no public market price. Caplight tracks Jacobian's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Jacobian worth (valuation)?
Valuation information for Jacobian is not publicly available.
Can I buy Jacobian stock?
Jacobian shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Jacobian's last funding round?
Jacobian's most recent funding round was Series C on April 22, 2024.
Who are the main investors in Jacobian?
Key investors in Jacobian include TVM Capital, European Investment Bank Group, Wessel Management, Yabeo Capital.
Will Jacobian IPO soon?
No public IPO plans have been announced for Jacobian.
How can I track Jacobian secondary market activity?
Caplight tracks bids, offers, and trades in Jacobian's shares on secondary markets.